Otoprotective effects of dexamethasone in the management of pneumococcal meningitis: An animal study

Laryngoscope

Volumn 117, Issue 7, 2007, Pages 1209-1215

  Kim, Harold H ^a   Addison, John ^b   Suh, Eul ^b   Trune, Dennis R ^c   Richter, Claus Peter ^b  

^a Wilson Ear Clinic   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Dexamethasone; Meningitis; Pneumococcus; Steroid; Streptococcus pneumonia

Indexed keywords

DEXAMETHASONE; PENICILLIN G;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; CELL DENSITY; CELL NUCLEUS; CHEMOPROPHYLAXIS; COCHLEA; COCHLEA DUCT; COCHLEA INJURY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOMETRY; DRUG EFFECT; EAR PROTECTION; EVOKED BRAIN STEM AUDITORY RESPONSE; EXPERIMENTAL INFECTION; FUNCTIONAL ASSESSMENT; GERBIL; HAIR CELL; HISTOPATHOLOGY; MONOTHERAPY; NERVE CELL; NONHUMAN; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; SPIRAL GANGLION; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS PNEUMONIAE; STRIA VASCULARIS; THICKNESS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL COUNT; COCHLEA; DEXAMETHASONE; DRUG THERAPY, COMBINATION; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GERBILLINAE; HEARING LOSS, SENSORINEURAL; INJECTIONS, INTRAPERITONEAL; MENINGITIS, PNEUMOCOCCAL; PENICILLINS; PROSPECTIVE STUDIES; RANDOM ALLOCATION; SPIRAL GANGLION; STREPTOCOCCUS PNEUMONIAE; TECTORIAL MEMBRANE;

EID: 34347369152     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e318058195f     Document Type: Article

References (26)

1. Haddy RI, Perry K, Chacko CE, etal. Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine. Pediatr Infect Dis J 2005;24:320-323.
2. Dodge PR, Davis H, Feigin RD, et al. Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N Engl J Med 1984;311:869-874.
3. Vernon M. Meningitis and deafness: the problem, its physical, audiological, psychological, and educational manifestations in deaf children. Laryngoscope 1967;77:1856-1874.
4. Fortnum HM. Hearing impairment after bacterial meningitis: a review. Arch Dis Child 1992;67:1128-1133.
5. Nadol JB Jr. Hearing loss as a sequela of meningitis. Laryngoscope 1978;88:739-755.
6. Klein M, Koedel U, Pfister HW, Kastenbauer S. Morphological correlates of acute and permanent hearing loss during experimental pneumococcal meningitis. Brain Pathol 2003;13:123-132.
7. Rauch SD, Herrmann BS, Davis LA. Nucleus 22 cochlear implantation results in postmeningitic deafness. Laryngoscope 1997;107:1606-1609.
8. El-Kashlan HK, Ashbaugh C, Zwolan T, Telian SA. Cochlear implantation in prelingually deaf children with ossified cochleae. Otol Neurotol 2003;24:596-600.
9. Nikolopoulos TP, O'Donoghue GM, Robinson KL, Gibbin KP, Archbold SM, Mason SM. Multichannel cochlear implantation in postmeningitic and congenitally deaf children. Am J Otol 1997;18:S147-S148.
10. Arditi M, Mason EO Jr, Bradley JS, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998;102:1087-1097.
11. Lebel MH, Freji BJ, Syrogiannopuolos GA. Dexamethasone therapy for bacterial meningitis. N Engl J Med 1988;319:964-971.
12. de Gans J, Van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002;347:1549-1556.
13. Klein M, Koedel U, Pfister HW, Kastenbauer S. Meningitis associated hearing loss: protection by adjunctive antioxidant therapy. Ann Neurol 2003;54:451-458.
14. McIntyre PB, Berkey CS, King SM, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A metaanalysis of randomized clinical trials since 1988. JAMA 1997;278:925-931.
15. Addison J, Kim HH, Richter CP. Cochlear preservation after meningitis: an animal model confirmation of adjunctive steroid therapy. Laryngoscope 2006;116:279-282.
16. Pearce M, Richter CP, Cheatham MA. A reconsideration of sound calibration in the mouse. J Neurosci Methods 2000;106:57-67.
17. Kesser BW, Hashisaki GT, Spindel JH, Ruth RA, Scheld WM. Time course of hearing loss in an animal model of pneumococcal meningitis. Otolaryngol Head Neck Surg 1999;120:628-637.
18. Rappaport JM, Bhatt SM, Burkard RF, Merchant SN, Nadol JB Jr. Prevention of hearing loss in experimental pneumococcal meningitis by administration of dexamethasone and ketorolac. J Infect Dis 1999;179:264-268.
19. Coggeshall RE, Lekan HA. Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J Comp Neurol 1996;364:6-15.
20. Guillery RW, Herrup K. Quantification without pontification: choosing a method for counting objects in sectioned tissue. J Comp Neurol 1997;386:2-7.
21. Linthicum FH, Anderson W. Cochlear implantation in totally deafened ears. Histologic evaluation of candidacy. Ann Otol Rhinol Laryngol 1991;111:327-331.
22. Nadol BJ Jr, Young YS, Glynn RJ. Survival of spiral ganglion cells in profound sensorineural hearing loss: implications for cochlear implantation. Ann Otol Rhinol Laryngol 1989;98:411-416.
23. Balkany T, Gantz BJ, Steenerson RL, Cohen NL. Systematic approach to electrode insertion in the ossified cochlea. Otolaryngol Head Neck Surg 1996;114:4-11.
24. MacArthur CJ, Hefeneider SH, Kempton JB, Trune DR. C3H/HeJ mouse model for spontaneous chronic otitis media. Laryngoscope 2006;116:1071-1079.
25. Gaheri BA, Kempton JB, Pillers DM, Trune DR. Cochlear cytokine gene expression in murine acute otitis media. Laryngoscope 2007;117:22-29.
26. Brodie HA, Thompson HC, Vassilian L, Lee BN. Induction of labyrinthitis ossificans after pneumococcal meningitis: an animal model. Otolaryngol Head Neck Surg 1998;118:15-21.